ClinicalTrials.Veeva

Menu

Development of a Polyphenol-rich Dietary Preparation for Treating Veterans With Gulf War Illness

Mount Sinai Health System logo

Mount Sinai Health System

Status and phase

Completed
Phase 2
Phase 1

Conditions

Gulf War Illness

Treatments

Dietary Supplement: Concord grape juice
Dietary Supplement: Placebo Beverage

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT02915237
GCO 13-1398

Details and patient eligibility

About

Gulf War Illness (GWI) is a multi-symptom disorder that is characterized by complex traits such as fatigue, headaches, joint pain, insomnia, and memory problems. With no treatment for GWI currently available, there is an urgent need to develop novel interventions to alleviate major GWI clinical complications. Recent evidence highlights the potential value of flavonoids, a subclass of organic chemical called polyphenols abundantly found in some plants and common dietary preparations, in helping relieve clinical complications in Veterans with GWI. The overall goal is to test whether daily consumption of commercially available Concord grape juice, which is very Flavonoid-rich, is effective for treating cognitive deficits and chronic fatigue in Veterans with GWI.

Full description

Gulf War Illness (GWI) is a multi-symptom disorder that is characterized by complex traits. Clinical complications of GWI typically persist over long-term, cause significant pain and suffering, and interfere with the ability of affected Veterans to successfully integrate back into civilian society. There is no treatment for GWI and there is an urgent need to develop novel interventions either to resolve underlying GWI mechanisms, or to alleviate major GWI clinical complications.

Recent Evidence highlights the potential value of flavonoids, a subclass of organic chemical called polyphenols that are abundantly found in some plants and common dietary preparations may help alleviate chronic fatigue and preserve cognitive functions. Based on this, the overall goal is to test whether the potential efficacy of dietary supplementation with a commercially available flavonoid-rich product, alleviates clinical complications in Veterans with GWI. In particular, the researchers propose a randomized, double-blind, placebo-controlled Phase I/IIA study to test the feasibility and potential efficacy of Concord grape juice dietary supplementation to treat cognitive deficits and chronic fatigue in Veterans with GWI.

Enrollment

36 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gulf War Veterans deployed to the Persian Gulf theatre between August 1990 and August 1991. GWI will be defined according to the Kansas Case Definition. The Kansas Case Definition identifies 6 symptom domains and requires endorsement of moderately severe and/or multiple symptoms in at least 3 of those domains. To meet the case definition, the Veterans must also indicate that each symptom first became problematic during or within one year of the Gulf War.

Exclusion criteria

  • Individuals not meeting the inclusion criteria for Gulf War deployment and definition of GWI, or with conditions that might interfere with their ability to report their symptoms (e.g., drug use) are excluded.
  • Additional exclusion criteria are current medical conditions that may explain the symptoms (diabetes, heart disease, among others) or significant current (in the past six months) unstable (requiring significant medication adjustments or hospitalization) psychiatric conditions, including suicidal or homicidal ideation, schizophrenia or bipolar disorder according to subject responses to the interview and review by the principal investigator.
  • Subjects who usually consume abnormally high contents of dietary polyphenol based on a self-reported diet diary will be excluded.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

36 participants in 6 patient groups, including a placebo group

Low Dose - Concord grape juice
Experimental group
Description:
Daily dietary supplementation with 4 oz. of a commercially available Concord grape juice.
Treatment:
Dietary Supplement: Concord grape juice
Moderate Dose - Concord grape juice
Experimental group
Description:
Daily dietary supplementation with 8 oz. of a commercially available Concord grape juice.
Treatment:
Dietary Supplement: Concord grape juice
High Dose - Concord grape juice
Experimental group
Description:
Daily dietary supplementation with 16 oz. of a commercially available Concord grape juice.
Treatment:
Dietary Supplement: Concord grape juice
Low dose - placebo beverage
Placebo Comparator group
Description:
Daily dietary supplementation with 4 oz. of a placebo beverage
Treatment:
Dietary Supplement: Placebo Beverage
Moderate Dose - placebo beverage
Placebo Comparator group
Description:
Daily dietary supplementation with 8 oz. of a placebo beverage
Treatment:
Dietary Supplement: Placebo Beverage
High Dose - placebo beverage
Placebo Comparator group
Description:
Daily dietary supplementation with 16 oz. of a placebo beverage
Treatment:
Dietary Supplement: Placebo Beverage

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems